does tirzepatide cause heart problems Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats GLP-1–Based Drug Tirzepatide Reduces Heart

In most cases, lifestyle changes and metformin remain the most practical and evidence-based options

In contrast to findings of improved glycemia in Dpp4 / mice, glucose tolerance was not enhanced in Dpp4 EC/ and Dpp4 EC/ (BMT) mice, despite reductions in DPP-4 activity of approximately 50% and approximately 25%, respectively (Figure 2, C and E, and Supplemental Figure 1, CF)

A baseline measurement of thyroid-stimulating hormone (TSH) and free thyroxine (free T4) is standard practice

If you're taking a GLP-1 receptor agonist (semaglutide) or a dual GLP-1/GIP receptor agonist (tirzepatide) for weight management, the results are probably impressive

Funding The work was funded by the Traditional Chinese Medicine Intervention of Metabolic Diseases Research Project, Grant/Award Number: 90020165120003